<?xml version="1.0" encoding="iso-8859-1" ?>
<rss version="2.0" xmlns:s="http://resources.bnet.com/">
<channel>
	<title><![CDATA[Emergent Biosolutions | Company News & Executive Profiles - EBS | BNET]]></title>
	<link><![CDATA[http://resources.bnet.com/topic/emergent+biosolutions.html?i=11]]></link>
	<description><![CDATA[Latest company news & analysis, recent events, stock quotes, earning call transcripts, with profiles and descriptions of top business executives for Emergent Biosolutions]]></description>
	<s:counts start="0" returned="10" found="85" />
	<language>en-us</language>
	<item>
		<title><![CDATA[Emergent Biosolutions: Buying Opportunity]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F177035-emergent-biosolutions-buying-opportunity%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Zachary Scheidt submits:   Emergent Biosolutions EBS has seen some disappointments over the last few months.  The company is the only provider of an FDA approved Anthrax vaccine and EBS primarily sells its products to the United States Strategic National Stockpile SNS.  While EBS enjoys a relative...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 08 Dec 2009 01:12:24 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/zachary+scheidt.html"><![CDATA[Zachary Scheidt]]></category>
		<category domain="http://resources.bnet.com/topic/emergent+biosolutions.html"><![CDATA[Emergent Biosolutions]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
		<category domain="tickers">EBS</category>
	</item>
	<item>
		<title><![CDATA[Emergent BioSolutions Inc. Q3 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-361974.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Yes, thank you, sir. Operator instructions. We possible moment to compile the list. Your first question comes from the line of Eric Schmidt with Cowen & Company. Eric Schmidt &#8211; Cowen & Company Good afternoon. Don, within the $39 million BioThrax sales this quarter, was there about...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 05 Nov 2009 19:30:19 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/eric+schmidt.html"><![CDATA[Eric Schmidt]]></category>
		<category domain="http://resources.bnet.com/topic/cowen+%2526+co..html"><![CDATA[Cowen & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/federal+government.html"><![CDATA[Federal Government]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/emergent+biosolutions.html"><![CDATA[Emergent Biosolutions]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
		<category domain="tickers">EBS</category>
	</item>
	<item>
		<title><![CDATA[Emergent BioSolutions: Little Risk, Potentially Huge Reward]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F154891-emergent-biosolutions-little-risk-potentially-huge-reward%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Zachary Scheidt submits:   Emergent BioSolutions EBS traded sharply higher after releasing earnings Friday morning see conference call transcript here.  The company reported a 68% increase in sales, leading to earnings of $0.48 per share.  Investors celebrated by driving the stock price up 16% on volume that...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Sun, 09 Aug 2009 02:32:23 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/zachary+scheidt.html"><![CDATA[Zachary Scheidt]]></category>
		<category domain="http://resources.bnet.com/topic/emergent+biosolutions.html"><![CDATA[Emergent Biosolutions]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
		<category domain="tickers">EBS</category>
	</item>
	<item>
		<title><![CDATA[Emergent BioSolutions Inc., Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-329601.html]]></link>
		<description><![CDATA[ Question-and-Answer Session Operator Operator Instructions  The first question comes from the line of Mona Ashiya - J.P. Morgan.  Mona Ashiya - J.P. Morgan On the new manufacturing infrastructure, I&#8217;m wondering what kind of time frame you are looking at to get the Maryland facility up and running...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 06 Aug 2009 19:56:10 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/facility.html"><![CDATA[Facility]]></category>
		<category domain="http://resources.bnet.com/topic/j.p.+morgan+chase+%2526+co..html"><![CDATA[J.P. Morgan Chase & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/manufacturing.html"><![CDATA[Manufacturing]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/emergent+biosolutions.html"><![CDATA[Emergent Biosolutions]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">JPM</category>
		<category domain="tickers">EBS,JPM</category>
	</item>
	<item>
		<title><![CDATA[Emergent BioSolutions Inc., Q2 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F154549-emergent-biosolutions-inc-q2-2009-earnings-call-transcript%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Emergent BioSolutions Inc., EBS   Q2 2009 Earnings Call   August 6, 2009 5:00 pm ET]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 06 Aug 2009 08:56:10 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/emergent+biosolutions.html"><![CDATA[Emergent Biosolutions]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
		<category domain="tickers">EBS</category>
	</item>
	<item>
		<title><![CDATA[Emergent BioSolutions Inc., Q1 2009 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-300115.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator  Operator Instructions Your first question comes from Cory Kasimov with J.P. Morgan.   Mona Ashiya - J.P. Morgan This is actually Mona for Cory.  In your prepared remarks you mentioned that you expect sales of BioThrax to continue beyond 2011.  I wondered if...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 07 May 2009 18:32:20 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/j.p.+morgan+chase+%2526+co..html"><![CDATA[J.P. Morgan Chase & Co.]]></category>
		<category domain="http://resources.bnet.com/topic/call+transcript.html"><![CDATA[Call Transcript]]></category>
		<category domain="http://resources.bnet.com/topic/earnings.html"><![CDATA[Earnings]]></category>
		<category domain="http://resources.bnet.com/topic/rpa.html"><![CDATA[rPA]]></category>
		<category domain="http://resources.bnet.com/topic/government.html"><![CDATA[Government]]></category>
		<category domain="http://resources.bnet.com/topic/healthcare.html"><![CDATA[Healthcare]]></category>
		<category domain="http://resources.bnet.com/topic/sales+strategy.html"><![CDATA[Sales Strategy]]></category>
		<category domain="http://resources.bnet.com/topic/asset+management.html"><![CDATA[Asset Management]]></category>
		<category domain="http://resources.bnet.com/topic/sales.html"><![CDATA[Sales]]></category>
		<category domain="http://resources.bnet.com/topic/operational+planning.html"><![CDATA[Operational Planning]]></category>
		<category domain="http://resources.bnet.com/topic/business+operations.html"><![CDATA[Business Operations]]></category>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/emergent+biosolutions.html"><![CDATA[Emergent Biosolutions]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">JPM</category>
		<category domain="tickers">EBS,JPM</category>
	</item>
	<item>
		<title><![CDATA[PharmAthene: Game Changing Contract Ahead]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F129820-pharmathene-game-changing-contract-ahead%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[SPAC Analytics submits: We expect PharmAthene PIP and Emergent Biosolutions EBS to sign nearly identical sized $500M+ U.S. government contracts to provide 25 million doses of anthrax vaccine each any day now  This is a game changing contract for PIP as PIP moves it into the league of vaccine...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Tue, 07 Apr 2009 12:23:37 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/spac+analytics.html"><![CDATA[SPAC Analytics]]></category>
		<category domain="http://resources.bnet.com/topic/emergent+biosolutions.html"><![CDATA[Emergent Biosolutions]]></category>
		<category domain="http://resources.bnet.com/topic/pharmathene+inc..html"><![CDATA[PharmAthene Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">PIP</category>
		<category domain="tickers">EBS,PIP</category>
	</item>
	<item>
		<title><![CDATA[VaxGen Still Looking to Return Value to Its Stockholders]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F127984-vaxgen-still-looking-to-return-value-to-its-stockholders%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Greenbackd submits:  VaxGen Inc VXGN is a bread-and-butter play for us. The company is trading at a substantial discount to its net cash position, has ended its cash-burning product development activities and is now &#8220;seeking to maximize the value of its remaining assets through a strategic transaction or series...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 26 Mar 2009 05:22:43 -0700</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/greenbackd.html"><![CDATA[Greenbackd]]></category>
		<category domain="http://resources.bnet.com/topic/emergent+biosolutions.html"><![CDATA[Emergent Biosolutions]]></category>
		<category domain="http://resources.bnet.com/topic/vaxgen+inc..html"><![CDATA[Vaxgen Inc.]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
		<category domain="http://rss.financialcontent.com/stocksymbol">VXGN</category>
		<category domain="tickers">EBS,VXGN</category>
	</item>
	<item>
		<title><![CDATA[Emergent BioSolutions Inc. Q4 2008 Earnings Call Transcript]]></title>
		<link><![CDATA[http://www.bnet.com/2462-14055_23-276589.html]]></link>
		<description><![CDATA[ Question-and-Answer SessionOperator Operator Instructions Your first question comes from the line of Craig Gordon - Cowen & Co. Craig Gordon - Cowen & Co. A couple of questions. First, I was not sure if I heard this right. Is rPA on clinical hold? Fuad El-Hibri No. Craig Gordon -...]]></description>
		<s:doctype><![CDATA[Earnings calls]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Fri, 06 Mar 2009 11:49:17 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/.html"><![CDATA[]]></category>
		<category domain="http://resources.bnet.com/topic/seeking+alpha.html"><![CDATA[Seeking Alpha]]></category>
		<category domain="http://resources.bnet.com/topic/emergent+biosolutions.html"><![CDATA[Emergent Biosolutions]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
		<category domain="tickers">EBS</category>
	</item>
	<item>
		<title><![CDATA[Emergent Biosolutions - Yet Another Failed Breakout]]></title>
		<link><![CDATA[http://dw.com.com/redir?destUrl=http%3A%2F%2Fseekingalpha.com%2Farticle%2F121426-emergent-biosolutions-yet-another-failed-breakout%3Fsource%3Dbnet&siteid=23&tag=seekingalpha]]></link>
		<description><![CDATA[Trader Mark submits:If I had a nickel for every failed breakout the past 9 months, I could start my own mutual fund. Emergent BioSolutions EBS is the latest in a long list. We had warned about the potential when we layered in some long exposure last Friday   The...]]></description>
		<s:doctype><![CDATA[External links]]></s:doctype>
		<enclosure url="http://i.bnet.com/images/200803/icon_seekingalpha.gif" type="image/gif" />
		<pubDate>Thu, 19 Feb 2009 03:37:42 -0800</pubDate>
		<category domain="http://resources.bnet.com/topic/biotech.html"><![CDATA[Biotech]]></category>
		<category domain="http://resources.bnet.com/topic/trader+mark.html"><![CDATA[Trader Mark]]></category>
		<category domain="http://resources.bnet.com/topic/emergent+biosolutions.html"><![CDATA[Emergent Biosolutions]]></category>
		<category domain="http://rss.financialcontent.com/stocksymbol">EBS</category>
		<category domain="tickers">EBS</category>
	</item>
</channel>
</rss>
